SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-216988
Filing Date
2020-08-12
Accepted
2020-08-12 07:02:58
Documents
1
Effectiveness Date
2020-08-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d943267ddefa14a.htm DEFA14A 26781
  Complete submission text file 0001193125-20-216988.txt   27940
Mailing Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877
Business Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36498 | Film No.: 201094056
SIC: 2836 Biological Products, (No Diagnostic Substances)